Viewing StudyNCT00172016



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00172016
Status: COMPLETED
Last Update Posted: 2012-04-30
First Post: 2005-09-13

Brief Title: A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-01
Start Date Type: None
Primary Completion Date: 2005-04
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-09-13
First Submit QC Date: September 13 2005
Study First Post Date: 2005-09-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-04-27
Last Update Post Date: 2012-04-30
Last Update Post Date Type: ESTIMATED